Chimera Investment Corporation  

(Public, NYSE:CIM)   Watch this stock  
Find more results for CIM
11.39
0.00 (0.00%)
Feb 11 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 10.89 - 16.45
Open     -
Vol / Avg. 0.00/1.84M
Mkt cap 2.15B
P/E 16.78
Div/yield 0.48/16.86
EPS 0.68
Shares 189.01M
Beta 0.88
Inst. own 62%
Feb 18, 2016
Q4 2015 Chimera Investment Corp Earnings Call - 10:00AM EST - Add to calendar
Feb 17, 2016
Q4 2015 Chimera Investment Corp Earnings Release - 4:00PM EST - Add to calendar
Dec 10, 2015
Chimera Investment Corp Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -22.78% 85.67%
Operating margin -22.78% 85.67%
EBITD margin - 73.95%
Return on average assets -1.22% 4.52%
Return on average equity -5.90% 16.98%
CDP Score - -

Address

520 Madison Ave Fl 32
NEW YORK, NY 10022-4213
United States - Map
+1-212-6262300 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Chimera Investment Corporation is a specialty finance company. The Company, through its subsidiaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities and various other asset classes. The Company is externally managed by Fixed Income Discount Advisory Company.

Officers and directors

Matthew Lambiase President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Robert Colligan Chief Financial Officer
Age: 43
Bio & Compensation  - Reuters
Choudhary Yarlagadda Chief Operating Officer
Bio & Compensation  - Reuters
Mohit Marria Chief Investment Officer
Age: 37
Bio & Compensation  - Reuters
Phillip John Kardis II General Counsel
Bio & Compensation  - Reuters
William B. Dyer Head - Underwriting
Age: 68
Bio & Compensation  - Reuters
Paul Donlin Non-Executive Independent Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Mark Abrams Independent Director
Age: 66
Bio & Compensation  - Reuters
Gerard Creagh Independent Director
Age: 56
Bio & Compensation  - Reuters
Paul A. Keenan Independent Director
Age: 48
Bio & Compensation  - Reuters